[Chronic bee paralysis virus - quo vadis? Incidence in Bavaria and consideration of therapeutic measures]. / Chronische-Bienenparalyse-Virus ­ quo vadis? Auftreten in Bayern und Betrachtung von Therapiemaßnahmen.

OBJECTIVE: Chronic bee paralysis virus (CBPV), a so far unclassified RNA virus that may cause neurological signs and hairless black syndrome in honey bees, has become increasingly prevalent in various European countries in recent years. The disease occasionally leads to immense losses of worker bees and a significant drop in performance, especially in strong colonies. The aim of this retrospective study was to analyse the spread of CBPV in Bavaria from 2018 to 2020 as well as to evaluate therapeutic measures. MATERIAL AND METHODS: In part 1 of the study, analysis results of the Tiergesundheitsdienst Bayern e. V. (Bavarian Animal Health Service) from 302 bee colonies were examined with regard to virus diagnostics and clinical signs with a focus on CBPV. In part 2, data collected with the help of a questionnaire regarding 105 CBPV-positive and symptomatic colonies were evaluated. RESULTS: In part 1, a significant (p = 0.004) increase in CBPV-positive samples from 2018 to 2020 was detected within Bavaria. In addition, the number of cases with clinical signs also increased during the last 2 years. Part 2 of the study showed a clustering of reports of initial onset of CBPV symptoms during springtime. The colonies mostly with a combination of symptoms recovered from the disease in 57 % of the cases. Therapeutic intervention was one decisive factor. A large number of different combinations of measures led to survival, and a lack of intervention mostly resulted in the death of the colony. In 62 % of the diseased and isolated colonies, isolation prevented further spread in the apiary. CONCLUSION UND CLINICAL RELEVANCE: Based on the results, CBPV occurred more frequently in connection with clinical signs in Bavaria in recent years. Due to the large number of applied combinations of measures, no evidence-based therapy recommendation may be derived based on the current evaluations. However, it has been shown that any therapeutic intervention is superior to withholding treatment. For precise therapy recommendations, trials with treatment under standard conditions are necessary.

Detection of a new piperideine alkaloid in the pygidial glands of some Stenus beetles.

Rove beetles of the genus Stenus produce and store bioactive alkaloids like stenusine (3), 3-(2-methylbut-1-enyl)pyridine (4), and cicindeloine (5) in their pygidial glands to protect themselves from predation and microorganismic infestation. The biosynthesis of stenusine (3), 3-(2-methylbut-1-enyl)pyridine (4), and cicindeloine (5) was previously investigated in Stenus bimaculatus, Stenus similis, and Stenus solutus, respectively. The piperideine alkaloid cicindeloine (5) occurs also as a major compound in the pygidial gland secretion of Stenus cicindeloides. The three metabolites follow the same biosynthetic pathway, where the N-heterocyclic ring is derived from L-lysine and the side chain from L-isoleucine. The different alkaloids are finally obtained by few modifications of shared precursor molecules, such as 2,3,4,5-tetrahydro-5-(2-methylbutylidene)pyridine (1). This piperideine alkaloid was synthesized and detected by GC/MS and GC at a chiral phase in the pygidial glands of Stenus similis, Stenus tarsalis, and Stenus cicindeloides.

The pygidial defense gland system of the Steninae (Coleoptera, Staphylinidae): morphology, ultrastructure and evolution.

The pygidial defense glands of the Steninae consist of two big (r1) and two smaller (r2) secretion filled sac-like reservoirs with associated secretory tissues and basal eversible membrane structures. The secretion is made up of deterrent and antimicrobial alkaloids stored in r1 as well as terpenes in r2. The gland cells filling r1 form a band shaped secretory tissue (g1) in an invagination of the reservoir membrane. The content of r2 is secreted by a tissue (g2) surrounding the efferent duct of r1 opposite to r2. In both gland tissues the secretion is produced in type IIIt gland cells and accumulates in an extracellular cavity surrounded by numerous microvilli of the gland cell membrane. After exocytosis the secretion enters an epicuticular duct and is transported to the corresponding reservoir via a conducting canal enclosed in at least one canal cell. While the structure of g1 is very similar in all species of the Steninae, g2 is often reduced. This reduction of the system r2/g2 is accompanied by a decreasing amount of terpenes in the total secretion and could be of interest for phylogenetic studies in the subfamily of the Steninae.

Biosynthesis of the defensive alkaloid cicindeloine in Stenus solutus beetles.

To protect themselves from predation and microorganismic infestation, rove beetles of the genus Stenus produce and store bioactive alkaloids like stenusine, 3-(2-methyl-1-butenyl)pyridine, and cicindeloine in their pygidial glands. The biosynthesis of stenusine and 3-(2-methyl-1-butenyl)pyridine was previously investigated in Stenus bimaculatus and Stenus similis, respectively. Both molecules follow the same biosynthetic pathway, where the N-heterocyclic ring is derived from L-lysine and the side chain from L-isoleucine. The different alkaloids are finally obtained by slight modifications of shared precursor molecules. The piperideine alkaloid cicindeloine occurs as a main compound additionally to (E)-3-(2-methyl-1-butenyl)pyridine and traces of stenusine in the pygidial gland secretion of Stenus cicindeloides and Stenus solutus. Feeding of S. solutus beetles with [D,(15)N]-labeled amino acids followed by GC/MS analysis techniques showed that cicindeloine is synthesized via the identical pathway and precursor molecules as the other two defensive alkaloids.

Biosynthesis of the defensive alkaloid (Z)-3-(2-methyl-1-butenyl)pyridine in Stenus similis beetles.

Most rove beetles of the genus Stenus protect themselves against microorganisms and predators such as ants and spiders by producing the alkaloid stenusine (1) in their pygidial glands. The biosynthesis of 1 was previously investigated in S. bimaculatus, where L-lysine forms the piperidine ring, L-isoleucine the side chain, and acetate the N-ethyl group. In addition to 1, S. similis keeps the pyridine alkaloid (Z)-3-(2-methyl-1-butenyl)pyridine (2) in its pygidial glands. Feeding S. similis beetles with [D,15N]-labeled amino acids followed by GC/MS analysis showed that L-Lys yields the pyridine ring and L-Ile the 2-methyl-1-butenyl side chain. Thus the alkaloids 1 and 2 probably share two precursor molecules in their biosynthesis.

New pyridine alkaloids from rove beetles of the genus Stenus (Coleoptera: Staphylinidae).

Three new pyridine alkaloids were detected in the pygidial glands of some Stenus species. The chemotaxonomic significance of the occurrence of these alkaloids and stenusine in different Stenus species is discussed. The antimicrobial properties of (Z)- and (E)-3-(2-methyl-1-butenyl)-pyridine and the deterrent activities of stenusine and norstenusine were investigated.